Loading…
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutatio...
Saved in:
Published in: | Breast cancer research and treatment 2006-11, Vol.100 (1), p.83-91 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193 |
container_end_page | 91 |
container_issue | 1 |
container_start_page | 83 |
container_title | Breast cancer research and treatment |
container_volume | 100 |
creator | GIANNINI, Giuseppe CAPALBO, Carlo RINALDI, Christian ZANI, Massimo FERRARO, Sergio FRATI, Luigi SCREPANTI, Isabella GULINO, Alberto RISTORI, Elisabetta RICEVUTO, Enrico SIDONI, Tina BUFFONE, Amelia CORTESI, Enrico MARCHETTI, Paolo SCAMBIA, Giovanni TOMAO, Silverio |
description | Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations. |
doi_str_mv | 10.1007/s10549-006-9225-9 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68985706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68985706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</originalsourceid><addsrcrecordid>eNpd0VFr1TAUB_AgirubfgBfJAj61u0kbZLmcV50DoaDoc8hTU-ko22uOe0Fv4Mfeu29Fwc-hIScXw6H_Bl7J-BSAJgrEqAqWwDowkqpCvuCbYQyZWGkMC_ZBoQ2ha5Bn7FzokcAsAbsa3YmdF0ZpWDD_n5Pe-z554ftteB-bA8nyX9hHvpuRD7Mk5-6NNKh6ImQaMBx4in-q3HaYZjyPBzMLuPe9zgG5N3Ibyffd37kTUZP0wquUuZp7_N6G_zCMo9-6PoO6Q17FX1P-Pa0X7CfX7_82H4r7u5vbrfXd0UolZ4KqXWjZBVja8umgcpj7VtZRq1EZcogMS6rBBA1YNBY2wDCtgtpLUYlbHnBPh377nL6PSNNbugoYN_7EdNMTte2Vgb0Aj_8Bx_TnMdlNieFrColZbUgcUQhJ6KM0e1yN_j8xwlwa07umJNbcnJrTm6d4P2p8dwM2D6_OAWzgI8n4Cn4Publpzp6drVUYGVZPgF5s5um</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212445224</pqid></control><display><type>article</type><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><source>Springer Nature</source><creator>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</creator><creatorcontrib>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</creatorcontrib><description>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-006-9225-9</identifier><identifier>PMID: 16847550</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Biological and medical sciences ; BRCA1 Protein - genetics ; BRCA2 Protein - genetics ; Breast cancer ; Breast Neoplasms - epidemiology ; Breast Neoplasms - etiology ; Breast Neoplasms - genetics ; Cancer research ; Female ; Female genital diseases ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Gynecology. Andrology. Obstetrics ; Humans ; Italy - epidemiology ; Male ; Mammary gland diseases ; Medical sciences ; Ovarian cancer ; Ovarian Neoplasms - epidemiology ; Ovarian Neoplasms - etiology ; Ovarian Neoplasms - genetics ; Pedigree ; Prevalence ; Tumors</subject><ispartof>Breast cancer research and treatment, 2006-11, Vol.100 (1), p.83-91</ispartof><rights>2006 INIST-CNRS</rights><rights>Springer Science+Business Media, LLC 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</citedby><cites>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18250923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16847550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GIANNINI, Giuseppe</creatorcontrib><creatorcontrib>CAPALBO, Carlo</creatorcontrib><creatorcontrib>RINALDI, Christian</creatorcontrib><creatorcontrib>ZANI, Massimo</creatorcontrib><creatorcontrib>FERRARO, Sergio</creatorcontrib><creatorcontrib>FRATI, Luigi</creatorcontrib><creatorcontrib>SCREPANTI, Isabella</creatorcontrib><creatorcontrib>GULINO, Alberto</creatorcontrib><creatorcontrib>RISTORI, Elisabetta</creatorcontrib><creatorcontrib>RICEVUTO, Enrico</creatorcontrib><creatorcontrib>SIDONI, Tina</creatorcontrib><creatorcontrib>BUFFONE, Amelia</creatorcontrib><creatorcontrib>CORTESI, Enrico</creatorcontrib><creatorcontrib>MARCHETTI, Paolo</creatorcontrib><creatorcontrib>SCAMBIA, Giovanni</creatorcontrib><creatorcontrib>TOMAO, Silverio</creatorcontrib><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><description>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</description><subject>Biological and medical sciences</subject><subject>BRCA1 Protein - genetics</subject><subject>BRCA2 Protein - genetics</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - etiology</subject><subject>Breast Neoplasms - genetics</subject><subject>Cancer research</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Genetic Predisposition to Disease</subject><subject>Germ-Line Mutation</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Ovarian Neoplasms - etiology</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Pedigree</subject><subject>Prevalence</subject><subject>Tumors</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpd0VFr1TAUB_AgirubfgBfJAj61u0kbZLmcV50DoaDoc8hTU-ko22uOe0Fv4Mfeu29Fwc-hIScXw6H_Bl7J-BSAJgrEqAqWwDowkqpCvuCbYQyZWGkMC_ZBoQ2ha5Bn7FzokcAsAbsa3YmdF0ZpWDD_n5Pe-z554ftteB-bA8nyX9hHvpuRD7Mk5-6NNKh6ImQaMBx4in-q3HaYZjyPBzMLuPe9zgG5N3Ibyffd37kTUZP0wquUuZp7_N6G_zCMo9-6PoO6Q17FX1P-Pa0X7CfX7_82H4r7u5vbrfXd0UolZ4KqXWjZBVja8umgcpj7VtZRq1EZcogMS6rBBA1YNBY2wDCtgtpLUYlbHnBPh377nL6PSNNbugoYN_7EdNMTte2Vgb0Aj_8Bx_TnMdlNieFrColZbUgcUQhJ6KM0e1yN_j8xwlwa07umJNbcnJrTm6d4P2p8dwM2D6_OAWzgI8n4Cn4Publpzp6drVUYGVZPgF5s5um</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>GIANNINI, Giuseppe</creator><creator>CAPALBO, Carlo</creator><creator>RINALDI, Christian</creator><creator>ZANI, Massimo</creator><creator>FERRARO, Sergio</creator><creator>FRATI, Luigi</creator><creator>SCREPANTI, Isabella</creator><creator>GULINO, Alberto</creator><creator>RISTORI, Elisabetta</creator><creator>RICEVUTO, Enrico</creator><creator>SIDONI, Tina</creator><creator>BUFFONE, Amelia</creator><creator>CORTESI, Enrico</creator><creator>MARCHETTI, Paolo</creator><creator>SCAMBIA, Giovanni</creator><creator>TOMAO, Silverio</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><author>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>BRCA1 Protein - genetics</topic><topic>BRCA2 Protein - genetics</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - etiology</topic><topic>Breast Neoplasms - genetics</topic><topic>Cancer research</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Genetic Predisposition to Disease</topic><topic>Germ-Line Mutation</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Ovarian Neoplasms - etiology</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Pedigree</topic><topic>Prevalence</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GIANNINI, Giuseppe</creatorcontrib><creatorcontrib>CAPALBO, Carlo</creatorcontrib><creatorcontrib>RINALDI, Christian</creatorcontrib><creatorcontrib>ZANI, Massimo</creatorcontrib><creatorcontrib>FERRARO, Sergio</creatorcontrib><creatorcontrib>FRATI, Luigi</creatorcontrib><creatorcontrib>SCREPANTI, Isabella</creatorcontrib><creatorcontrib>GULINO, Alberto</creatorcontrib><creatorcontrib>RISTORI, Elisabetta</creatorcontrib><creatorcontrib>RICEVUTO, Enrico</creatorcontrib><creatorcontrib>SIDONI, Tina</creatorcontrib><creatorcontrib>BUFFONE, Amelia</creatorcontrib><creatorcontrib>CORTESI, Enrico</creatorcontrib><creatorcontrib>MARCHETTI, Paolo</creatorcontrib><creatorcontrib>SCAMBIA, Giovanni</creatorcontrib><creatorcontrib>TOMAO, Silverio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GIANNINI, Giuseppe</au><au>CAPALBO, Carlo</au><au>RINALDI, Christian</au><au>ZANI, Massimo</au><au>FERRARO, Sergio</au><au>FRATI, Luigi</au><au>SCREPANTI, Isabella</au><au>GULINO, Alberto</au><au>RISTORI, Elisabetta</au><au>RICEVUTO, Enrico</au><au>SIDONI, Tina</au><au>BUFFONE, Amelia</au><au>CORTESI, Enrico</au><au>MARCHETTI, Paolo</au><au>SCAMBIA, Giovanni</au><au>TOMAO, Silverio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</atitle><jtitle>Breast cancer research and treatment</jtitle><addtitle>Breast Cancer Res Treat</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>100</volume><issue>1</issue><spage>83</spage><epage>91</epage><pages>83-91</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>16847550</pmid><doi>10.1007/s10549-006-9225-9</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6806 |
ispartof | Breast cancer research and treatment, 2006-11, Vol.100 (1), p.83-91 |
issn | 0167-6806 1573-7217 |
language | eng |
recordid | cdi_proquest_miscellaneous_68985706 |
source | Springer Nature |
subjects | Biological and medical sciences BRCA1 Protein - genetics BRCA2 Protein - genetics Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - etiology Breast Neoplasms - genetics Cancer research Female Female genital diseases Genes, BRCA1 Genes, BRCA2 Genetic Predisposition to Disease Germ-Line Mutation Gynecology. Andrology. Obstetrics Humans Italy - epidemiology Male Mammary gland diseases Medical sciences Ovarian cancer Ovarian Neoplasms - epidemiology Ovarian Neoplasms - etiology Ovarian Neoplasms - genetics Pedigree Prevalence Tumors |
title | Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20BRCA1%20and%20BRCA2%20germline%20mutations%20and%20assessment%20of%20mutation%20spectrum%20and%20prevalence%20in%20Italian%20breast%20and/or%20ovarian%20cancer%20families&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=GIANNINI,%20Giuseppe&rft.date=2006-11-01&rft.volume=100&rft.issue=1&rft.spage=83&rft.epage=91&rft.pages=83-91&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1007/s10549-006-9225-9&rft_dat=%3Cproquest_cross%3E68985706%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212445224&rft_id=info:pmid/16847550&rfr_iscdi=true |